Chang, W.-L.; Yang, K.-C.; Peng, J.-Y.; Hong, C.-L.; Li, P.-C.; Chye, S.M.; Lu, F.-J.; Shih, C.-W.; Chen, C.-H.
Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation. Nutrients 2024, 16, 3020.
https://doi.org/10.3390/nu16173020
AMA Style
Chang W-L, Yang K-C, Peng J-Y, Hong C-L, Li P-C, Chye SM, Lu F-J, Shih C-W, Chen C-H.
Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation. Nutrients. 2024; 16(17):3020.
https://doi.org/10.3390/nu16173020
Chicago/Turabian Style
Chang, Wan-Ling, Kai-Chien Yang, Jyun-Yu Peng, Chain-Lang Hong, Pei-Ching Li, Soi Moi Chye, Fung-Jou Lu, Ching-Wei Shih, and Ching-Hsein Chen.
2024. "Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation" Nutrients 16, no. 17: 3020.
https://doi.org/10.3390/nu16173020
APA Style
Chang, W.-L., Yang, K.-C., Peng, J.-Y., Hong, C.-L., Li, P.-C., Chye, S. M., Lu, F.-J., Shih, C.-W., & Chen, C.-H.
(2024). Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation. Nutrients, 16(17), 3020.
https://doi.org/10.3390/nu16173020